Kestra Medical Technologies, Ltd.
KMTSHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, Kestra Medical Technologies, Ltd. (KMTS) is listed under Medical Instruments & Supplies. Valued at $1.71B, KMTS is a small-cap name in its sector. operates as a wearable medical device and digital healthcare company.
Market Cap
$1.71B
Beta
—
P/E (TTM)
—
P/E (Fwd)
-14.00
EPS (TTM)
$-2.71
EPS (Fwd)
$-2.06
ROE
-73.7%
ROA
-29.2%
Cash
$198.9M
Total Debt
$76.4M
Free CF
-$72.0M
52W Change
10.6%
Annual Financials
Cash vs Debt
Where KMTS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, KMTS finished 25.84% above its 150-day moving average ($23.34) and 24.45% above its 200-day moving average ($23.60). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is KMTS overbought or oversold?
At the October 20, 2026 close, KMTS's RSI(14) was 53.1, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $198.9M in cash and $76.4M in debt, KMTS maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. The company is burning cash, with free cash flow at -$72.0M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -73.7%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Kestra Medical Technologies, Ltd.'s trajectory.